FindTrial
Sign In

Translational Research for Establishing Novel Prevention and nobel procedure in Cardiovascular Disease

Translational Research for Establishing Novel Prevention and nobel procedure in Cardiovascular Disease - EHIME-CVS

Status
Recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000054173
Enrollment
500
Registered
2024-04-20
Start date
2019-04-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary artery lesions, valvular disease, aortic dissection (aortic wall), aortic aneurysm, aortic root dilatation, peripheral artery disease, Varicose veins

Interventions

None listed

Sponsors

Ehime University Graduate School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: A person who performs surgical treatment in cardiovascular surgery

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

MeasureTime frame
Pathological tests are performed on diseased and relatively unaffected tissues to identify therapeutic target factors by detailed analysis at the molecular, cellular, and tissue levels, and by comparative analysis of the composition of the two. Specifically, proteins and metabolic molecules are characterized using mass spectrometry, nucleic acids (called RNA) are characterized using sequencers, cells are characterized using temporary incubators, and tissues are characterized using special stains and immunohistochemical stains. In addition, imaging studies are used to evaluate preoperative and postoperative disease—

Secondary

MeasureTime frame
Blood tests, patient subjective assessment—

Countries

Japan

Contacts

Public ContactHironori Izutani

Ehime University Graduate School of Medicine Ehime University Graduate School of Medicine

shinkoge@m.ehime-u.ac.jp0899605331

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026